Key result
Heparin and warfarin remain drugs of choice for thromboembolism when optimized by specific assays.
Population
Patients with conditions associated with thromboembolism (cardiac, cerebral, and peripheral vascular disease)
Design
Review
Authors
Loading...
Supports monitoring-guided heparin and warfarin use in thromboembolism; extends mechanistic and dosing insights for future studies.
This review provides practical guidelines and pharmacological insights for optimizing the use of heparin and warfarin in managing thromboembolic conditions.
Wessler et al. (1986) conducted a review in Thromboembolic obstruction. Heparin and warfarin was evaluated. Heparin and warfarin are the drugs of choice for many conditions associated with thromboembolism, with specific guidelines and assays available to improve their benefit-to-risk ratios.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: